JUL 11, 2017 6:53 PM PDT

Treatment for Mitochondrial Disease in Development

WRITTEN BY: Carmen Leitch

Mitochondria are special parts of the cell, crucial organelles that generate power. They are also the only organelles that carry a small amount of their DNA. Researchers have now demonstrated that it is possible for a synthetic molecule to bind to that DNA. That’s big news in the fight against mitochondrial diseases, which are caused by mutations in the DNA carried by the mitochondria.

This is a schematic illustration of a mitochondria-specific DNA-based synthetic ligand, called MITO-PIPs that selectively read a target DNA sequence and alter gene transcription. / Credit: Kyoto University iCeMS

Unique compounds called pyrrole-imidazole polyamides (PIPs) identify specific sequences of DNA in live cells, and they can silence genes that cause disease. To do this, they stop transcription factors, special proteins that affect gene expression, from binding to DNA. That, in turn, stops the expression of the diseased genes. However, while PIPs can get into the nucleus of a cell and bind to the nuclear DNA inside, they cannot cross the membrane of mitochondria.

Led by Ganesh Pandian Namasivayam at Kyoto University's Institute for Integrated Cell-Material Science (iCeMS), a research team has now been able to get PIPs across the mitochondrial membrane. Thus, they can now influence the transcription of mitochondrial DNA. They have reported their findings in the Journal of the American Chemical Society.

To enable the PIP to overcome the energy barrier of a mitochondrion, the scientists added an MPP - mitochondria-penetrating peptide. The new molecule, an MPP conjugated PIP or MITO-PIP, was engineered to block the binding site of TFAM, mitochondrial transcription factor A. TFAM is critical to the regulation of metabolism and energy synthesis in the mitochondria; it influences the expression of the ND6 gene, first author Takuya Hidaka explained.

The investigators determined that TFAM-inhibiting MITO-PIP was able to find a mitochondrial DNA sequence and reduce the expression of ND6 by 60 to 90 percent, depending on what concentration the scientists used. They tracked the MITO-PIPs into mitochondria, confirming they did not affect gene expression in the nucleus by using fluorescent labeling of the compound.

The ND6 gene has been linked to several mitochondrial diseases. They include Leber's hereditary optic neuropathy, in which affected patients lose central vision, dystonia, a disease of muscle movement, and Leber's hereditary optic neuropathy. As such, these mitochondrial diseases are prime targets for researchers aiming to improve the lives of patients through clinical tools. The investigators are continuing to work to that end. "We plan to develop an advanced version of MITO-PIPs that can identify and localize only inside diseased mitochondria," said Ganesh. 

Currently, only symptom management is possible with mitochondrial disorders, and this could be a new, powerful way to treat these diseases.

"Our proof-of-concept study provides a fresh platform that opens new avenues for DNA-based functional ligands that are capable of altering the mitochondrial genome in a sequence-specific manner," concluded Hiroshi Sugiyama, the principal investigator.

In the video above, Namasivayam discusses his work.

 

Sources: AAAS/Eurekalert! Via Kyoto University News, Journal of the American Chemical Society

About the Author
BS
Experienced research scientist and technical expert with authorships on over 30 peer-reviewed publications, traveler to over 70 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
JUN 11, 2022
Neuroscience
Social Isolation is an Independent Risk Factor for Dementia
JUN 11, 2022
Social Isolation is an Independent Risk Factor for Dementia
Socially isolated people are 26% more likely than individuals with more active social connections to develop dementia la ...
JUN 20, 2022
Cell & Molecular Biology
Rethinking What We Know About Blood Cell Formation
JUN 20, 2022
Rethinking What We Know About Blood Cell Formation
An image by Sachin H. Patel/Boston Children's Hospital shows embryonic multipotent progenitor cells in a mouse embryo's ...
JUN 28, 2022
Neuroscience
Processing Sad Emotions
JUN 28, 2022
Processing Sad Emotions
A study published in Communications Biology focused on the neural mechanisms of the pons-corticolimbic network, with spe ...
JUL 12, 2022
Drug Discovery & Development
Nitric Oxide Reduces Hospital Stay of Pregnant Women with COVID-19
JUL 12, 2022
Nitric Oxide Reduces Hospital Stay of Pregnant Women with COVID-19
High-dose nitric oxide can reduce the length of hospital and ICU stay, as well as the need for supplemental oxygen, amon ...
AUG 09, 2022
Clinical & Molecular DX
Artificial Intelligence Can Now Diagnose Chagas Disease Using a Phone's Camera
AUG 09, 2022
Artificial Intelligence Can Now Diagnose Chagas Disease Using a Phone's Camera
Chagas Disease is caused by a parasite called T. cruzi. Primarily found in Latin America, it is transmitted to humans by ...
AUG 18, 2022
Clinical & Molecular DX
New Research Investigates the Molecular Spread of Triple-Negative Breast Cancer
AUG 18, 2022
New Research Investigates the Molecular Spread of Triple-Negative Breast Cancer
Triple-negative breast cancer (TNBC) accounts for 10-15% of all breast cancer cases. TNBC is a term used to describe cas ...
Loading Comments...